Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1706 of 6351
-
Balloon 'Postconditioning' may shield brain after stroke
Disease control CompletedThis study aims to determine the safety and optimal dose of rapid local ischemic postconditioning in acute ischemic stroke(AIS) patients received successful thrombectomy reperfusion. In this trial, investigators will halt antegrade cerebral blood flow temporarily by the way of ba…
Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Wearable patch and phone app could spot dangerous fevers before they spike in cancer therapy
Knowledge-focused CompletedThe purpose of this study is to evaluate two vital sign monitoring devices, TempTraq and VitalTraq, in patients with hematologic malignancies undergoing therapy with Chimeric antigen receptor T-cell therapy (CAR-T) or Bispecific T-cell engagers (BiTE) products. TempTraq is an axi…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
New pill shows promise for kidney disease patients
Disease control CompletedEvaluate the efficacy and safety of HSK39297 tablets in patients with primary IgAN
Phase 2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Poop pills vs. pancreatitis: can gut transplants stop deadly infections?
Disease control Recruiting nowThis study is a randomized, double-blind and placebo-controlled study. The purpose of this study is to evaluate the efficacy and safety of FMT in patients with moderate to severe acute pancreatitis.
Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:29 UTC
-
Could a pill keep AML at bay? new study tests maintenance therapy after chemo
Disease control CompletedApproximately 10% of patient develop AML after chemotherapy or radiation for unrelated disease (t-AML) and 20% have AML with an antecedent hematologic disorder (AML-MRC). CPX-351 (Vyxeos), a liposomal formulation of a fixed molar ratio (1:5) daunorubicin and cytarabine, has been …
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can a diabetes drug boost weight loss after teen bariatric surgery?
Disease control Recruiting nowThe study plans to learn more about what happens to the body after bariatric surgery in people 12 to 24 years old. The study aims to understand why people respond differently to bariatric surgery and how to define success beyond weight loss alone. The study also plans to learn mo…
Phase 1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Smart test could tailor breast cancer treatment and boost quality of life
Diagnosis Recruiting nowThe primary goal of the DEFINITIVE trial is to demonstrate the effectiveness of the HER2DX diagnostic assay in enhancing the management of patients with early-stage HER2- positive breast cancer. Patients randomized to arm A will receive adjuvant treatment by physician´s choice, …
Sponsor: Fundacio Clinic Barcelona • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
New pill aims to protect kidneys in diabetes patients
Disease control Recruiting nowThe goal of this clinical trial is to to investigate whether the drug R3R01 has a beneficial effect on the amount of protein excreted in the urine in adult patients (above 18 years of age) with type 2 diabetes and resulting kidney disease. The main questions it aims to answer ar…
Phase 2 • Sponsor: River 3 Renal Corp. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a probiotic gummy help kids with allergies?
Symptom relief CompletedTo evaluate the effect of probiotic gummies on symptoms of allergic rhinitis, immune-inflammatory factors, and host metabolism in children with allergic rhinitis compared with placebo.
Sponsor: Wecare Probiotics Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New antibody drug aims to tame ulcerative colitis
Disease control Recruiting nowThe Phase 1 study described herein will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XmAb942 in healthy volunteers (Parts A and B). Part C of this study will be a Phase 2 study to evaluate XmAb942 in participants with ulcerative colitis (UC).
Phase 1/2 • Sponsor: Xencor, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New pill RAP-219 tested for stubborn seizures
Disease control CompletedThis is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine if RAP-219 works and is safe in patients with Refractory Focal Epilepsy.
Phase 2 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New migraine pill shows promise in large trial
Symptom relief CompletedThis study is designed to identify at least one dose of BHV-2100 that is safe and effective in reducing headache pain and other symptoms in the treatment of migraine.
Phase 2 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New combo therapy aims to control bladder cancer without surgery
Disease control Recruiting nowTo learn if the combination of enfortumab vedotin plus radiation therapy could help to control the disease.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a better HER2 test predict who responds to targeted therapy?
Diagnosis Recruiting nowThis study will assess whether a quantitative, HER2 assay can accurately and reliably discriminate between responders and non-responders among patients with HER2 IHCI+ metastatic breast cancer who are receiving T-Dxd.
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
New hope for rare blood disorder: ravulizumab trial shows promise in china
Disease control CompletedThe primary objective of this study is to evaluate the efficacy of ravulizumab in adult participants with PNH.
Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for tough leukemia: first human trial of KK2845 begins
Disease control Recruiting nowThis is the first in human study of KK2845. This clinical trial consists of Part 1 (Dose Escalation) and Part 2 (Backfill). For patients with relapsed or refractory acute myeloid leukemia (AML) and other Hematologic Malignancies, in Part 1, the tolerability of KK2845 will be eva…
Phase 1 • Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can a simple screening help parents in child welfare get the mental health support they need?
Knowledge-focused CompletedThe main aim of this study is to evaluate the feasibility, preliminary effects and experiences of the Collaboration-Screening-Referral approach (in Swedish: Samverkan-Screening-Hänvisning - SSH) when used with parents referred to the Swedish child welfare services. The SSH is an …
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Immune cells trained to fight ovarian cancer in new trial
Disease control Recruiting nowThe goal of this research study is to evaluate the safety and effectiveness of the use of cytokine-induced memory-like (CIML) natural killer (NK) cell therapy in recurrent, high grade ovarian cancer (HGOC). Names of the study therapies involved in this study are: CIML NK (cellu…
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Midwife-Led birth units may boost Parents' mental health years after childbirth
Knowledge-focused CompletedMajority of pregnancies and childbirths in France occur without complication. While the impact of care failure on maternal and neonatal morbi-mortality is now well- established, the literature reveals that an overmedicalization of pregnancy and childbirth care is not associated w…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New study hopes to spot cancer early in NF1 patients
Knowledge-focused Recruiting nowBackground: Neurofibromatosis type 1 (NF1) is a genetic disease that can cause many symptoms. About half of people with NF1 will develop benign (noncancerous) tumors along nerves in the skin, brain, and other parts of the body. Sometimes, though, these tumors can become cancerou…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC